Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Infectious Diseases
Published in: BMC Infectious Diseases 1/2019

Open Access 01-12-2019 | Vaccination | Research article

Third national biobank for population-based seroprevalence studies in the Netherlands, including the Caribbean Netherlands

Authors: Janneke Doortje Maria Verberk, Regnerus Albertus Vos, Liesbeth Mollema, Jeffrey van Vliet, Joanna Wilhelmina Maria van Weert, Hester Ellen de Melker, Fiona Regina Maria van der Klis

Published in: BMC Infectious Diseases | Issue 1/2019

Login to get access

Abstract

Background

This paper outlines the methodology, study population and response rate of a third large Dutch population-based cross-sectional serosurvey carried-out in 2016/2017, primarily aiming to obtain insight into age-specific seroprevalence of vaccine-preventable diseases to evaluate the National Immunization Programme (NIP). In addition, Caribbean Netherlands (CN) was included, which enables additional research into tropical pathogens.

Methods

A two-stage cluster sampling technique was used to draw a sample of Dutch residents (0–89 years) (NS), including an oversampling of non-Western migrants, persons living in low vaccination coverage (LVC) areas, and an extra sample of persons born in Suriname, Aruba and the former Dutch Antilles (SAN). A separate sample was drawn for each Caribbean island. At the consultation hours, questionnaires, blood samples, oro- and nasopharyngeal swabs, faeces, − and only in the Netherlands (NL) saliva and a diary about contact patterns – were obtained from participants. Vaccination- and medical history was retrieved, and in CN anthropometric measurements were taken.

Results

In total, blood samples and questionnaires were collected from 9415 persons: 5745 (14.4%) in the NS (including the non-Western migrants), 1354 (19.8%) in LVC areas, 501 (6.9%) SAN, and 1815 (23.4%) in CN.

Conclusions

This study will give insight into protection of the population against infectious diseases included in the NIP. Research based on this large biobank will contribute to public health (policy) in NL and CN, e.g., regarding outbreak management and emerging pathogens. Further, we will be able to extend our knowledge on infectious diseases and its changing dynamics by linking serological data to results from additional materials collected, environmental- and pharmacological data.
Appendix
Available only for authorised users
Literature
1.
de Melker HE, van den Hof S, Berbers GA, Conyn-van Spaendonck MA. Evaluation of the national immunisation programme in the Netherlands: immunity to diphtheria, tetanus, poliomyelitis, measles, mumps, rubella and Haemophilus influenzae type b. Vaccine. 2003;21:716–20.CrossRef
2.
van der Klis FR, Mollema L, Berbers GA, de Melker HE, Coutinho RA. Second national serum bank for population-based seroprevalence studies in the Netherlands. Neth J Med. 2009;67(7):301–8.PubMed
3.
Waaijenborg S, Hahne SJ, Mollema L, Smits GP, Berbers GA, van der Klis FR, de Melker HE, Wallinga J. Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage. J Infect Dis. 2013;208(1):10–6.CrossRef
4.
Steens A, Mollema L, Berbers GA, van Gageldonk PG, van der Klis FR, de Melker HE. High tetanus antitoxin antibody concentrations in the Netherlands: a seroepidemiological study. Vaccine. 2010;28(49):7803–9.CrossRef
5.
de Voer RM, Mollema L, Schepp RM, de Greeff SC, van Gageldonk PG, de Melker HE, Sanders EA, Berbers GA, van der Klis FR. Immunity against Neisseria meningitidis serogroup C in the Dutch population before and after introduction of the meningococcal c conjugate vaccine. PLoS One. 2010;5(8):e12144.CrossRef
6.
Woudenberg T, van Binnendijk RS, Sanders EA, Wallinga J, de Melker HE, Ruijs WL, Hahne SJ. Large measles epidemic in the Netherlands, may 2013 to march 2014: changing epidemiology. Euro surveillance : bulletin Europeen Sur les maladies transmissibles = European communicable disease bulletin, vol. 22; 2017. p. 3.
7.
Sane J, Gouma S, Koopmans M, de Melker H, Swaan C, van Binnendijk R, Hahne S. Epidemic of mumps among vaccinated persons, the Netherlands, 2009-2012. Emerg Infect Dis. 2014;20(4):643–8.CrossRef
8.
Knol MJ, Hahne SJM, Lucidarme J, Campbell H, de Melker HE, Gray SJ, Borrow R, Ladhani SN, Ramsay ME, van der Ende A. Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study. Lancet Public Health. 2017;2(10):e473–e82.CrossRef
9.
Swart EM, van Gageldonk PG, de Melker HE, van der Klis FR, Berbers GA, Mollema L. Long-term protection against diphtheria in the Netherlands after 50 years of vaccination: results from a Seroepidemiological study. PLoS One. 2016;11(2):e0148605.CrossRef
10.
Mollema L, de Melker HE, Swart E, van Weert YRM, van der Klis FRM. Start derde landelijke sero-epidemiologisch onderzoek (Pienter3). Ned Tijdschr Med Microbio. 2016;24(1):48–51.
11.
Pan American Health Organization / World Health Organization. Epidemiological update: measles. 20 august 2018. Washington, D.C.: PAHO/WHO; 2018.
12.
Pan American Health Organization / World Health Organization. Epidemiological update: diphtheria. In: 29 August, vol. 2018. Washington: D.C.; 2018.
13.
Colon-Gonzalez FJ, Peres CA, Steiner Sao Bernardo C, Hunter PR, Lake IR. After the epidemic: Zika virus projections for Latin America and the Caribbean. PLoS Negl Trop Dis. 2017;11(11):e0006007.CrossRef
14.
Torres JR, Orduna TA, Pina-Pozas M, Vazquez-Vega D, Sarti E. Epidemiological characteristics of dengue disease in Latin America and in the Caribbean: a systematic review of the literature. J Trop Med. 2017;2017:8045435.CrossRef
15.
Van Bortel W, Dorleans F, Rosine J, Blateau A, Rousset D, Matheus S, Leparc-Goffart I, Flusin O, Prat C, Cesaire R, Najioullah F, Ardillon V, Balleydier E, Carvalho L, Lemaitre A, Noel H, Servas V, Six C, Zurbaran M, Leon L, Guinard A, van den Kerkhof J, Henry M, Fanoy E, Braks M, Reimerink J, Swaan C, Georges R, Brooks L, Freedman J, Sudre B, Zeller H. Chikungunya outbreak in the Caribbean region, December 2013 to March 2014, and the significance for Europe. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 2014;19(13).
16.
van Lier EA, Geraedts JLE, Oomen PJ, Giesbers H, van Vliet JA, Drijfhout IH, Zonnenberg-Hoff IF, de Melker HE. Vaccinatiegraad en jaarverslag Rijksvaccinatieprogramma Nederland 2016. [Vaccination coverage and annual report National Immunisation Programme Netherlands 2016]. Bilthoven: National Institute for Public Health and the Environment (RIVM). Contract No.: RIVM report 2017–0010.
17.
18.
Eeftens M, Beelen R, de Hoogh K, Bellander T, Cesaroni G, Cirach M, Declercq C, Dedele A, Dons E, de Nazelle A, Dimakopoulou K, Eriksen K, Falq G, Fischer P, Galassi C, Grazuleviciene R, Heinrich J, Hoffmann B, Jerrett M, Keidel D, Korek M, Lanki T, Lindley S, Madsen C, Molter A, Nador G, Nieuwenhuijsen M, Nonnemacher M, Pedeli X, Raaschou-Nielsen O, Patelarou E, Quass U, Ranzi A, Schindler C, Stempfelet M, Stephanou E, Sugiri D, Tsai MY, Yli-Tuomi T, Varro MJ, Vienneau D, Klot S, Wolf K, Brunekreef B, Hoek G. Development of land use regression models for PM(2.5), PM(2.5) absorbance, PM(10) and PM(coarse) in 20 European study areas; results of the ESCAPE project. Environmental science & technology. 2012;46(20):11195–205.CrossRef
19.
Klompmaker JO, Hoek G, Bloemsma LD, Gehring U, Strak M, Wijga AH, van den Brink C, Brunekreef B, Lebret E, Janssen NAH. Green space definition affects associations of green space with overweight and physical activity. Environ Res. 2018;160:531–40.CrossRef
20.
21.
Mindell JS, Giampaoli S, Goesswald A, Kamtsiuris P, Mann C, Mannisto S, Morgan K, Shelton NJ, Verschuren WM, Tolonen H. Sample selection, recruitment and participation rates in health examination surveys in Europe-experience from seven national surveys. BMC Med Res Methodol. 2015;15:78.CrossRef
22.
23.
24.
25.
26.
27.
28.
29.
30.
Blokstra A VP, Venmans LMAJ, Holleman P, van der Schouw YT, Smit HA, Verschuren WMM. Nederland de Maat Genomen, 2009–2010. RIVM Report 260152001/2011; 2011.
31.
Scholtens S, Smidt N, Swertz MA, Bakker SJ, Dotinga A, Vonk JM, van Dijk F, van Zon SK, Wijmenga C, Wolffenbuttel BH, Stolk RP. Cohort profile: LifeLines, a three-generation cohort study and biobank. Int J Epidemiol. 2015;44(4):1172–80.CrossRef
32.
Allen N, Sudlow C, Downey P, Peakman T, Danesh J, Elliott P, Gallacher JG, Green J, Matthews P, Pell J, Sprosen T, Collins R. UK Biobank: Current status and what it means for epidemiology. Health Policy Technol 2012;1(3):123–6.CrossRef
33.
Chapman BA, Burt MJ, Frampton CM, Collett JA, Yeo KH, Wilkinson ID, Cook HB, Barclay MJ, Ross AG, George PM. The prevalence of viral hepatitis (HAV, HBV and HCV) in the Christchurch community. The New Zealand medical journal. 2000;113(1118):394–6.PubMed
34.
Kelly H, Riddell MA, Gidding HF, Nolan T, Gilbert GL. A random cluster survey and a convenience sample give comparable estimates of immunity to vaccine preventable diseases in children of school age in Victoria, Australia. Vaccine. 2002;20(25–26):3130–6.CrossRef
35.
36.
Grievink L, Fuchs G, O'Niel J, van Sonderen E, Gerstenbluth I, Alberts JF. The Bonaire health study; methodology and main results. Curaçao: Foundation for Promotion of International Cooperation & Research in healthcare. In: ISOG; 2002.
37.
Grievink L, Fuchs G, O'Niel J, van Sonderen E, Gerstenbluth I, Alberts JF. The St. Eustatius health study; methodology and main results. Curaçao: Foundation for Promotion of International Cooperation & Research in healthcare. In: ISOG; 2002.
38.
Grievink L, Fuchs G, O'Niel J, van Sonderen E, Gerstenbluth I, Alberts JF. The Saba health study; methodology and main results. Curaçao: Foundation for Promotion of International Cooperation & Research in healthcare. In: ISOG; 2002.
39.
Desselberger U. The mammalian intestinal microbiome: composition, interaction with the immune system, significance for vaccine efficacy, and potential for disease therapy. Pathogens. 2018;7(3).CrossRef
Metadata
Title
Third national biobank for population-based seroprevalence studies in the Netherlands, including the Caribbean Netherlands
Authors
Janneke Doortje Maria Verberk
Regnerus Albertus Vos
Liesbeth Mollema
Jeffrey van Vliet
Joanna Wilhelmina Maria van Weert
Hester Ellen de Melker
Fiona Regina Maria van der Klis
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Vaccination
Published in
BMC Infectious Diseases / Issue 1/2019
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-019-4019-y

Other articles of this Issue 1/2019

BMC Infectious Diseases 1/2019 Go to the issue

Research article

The impact of homocysteine, B12, and D vitamins levels on functional neurocognitive performance in HIV-positive subjects

Research article

Viral suppression rate among children tested for HIV viral load at the Amhara Public Health Institute, Bahir Dar, Ethiopia

Research article

Molecular and descriptive epidemiology of intestinal protozoan parasites of children and their pets in Cauca, Colombia: a cross-sectional study

Research article

Potential circulating biomarkers of circulating chemokines CCL5, MIP-1β and HA as for early detection of cirrhosis related to chronic HBV (hepatitis B virus) infection

Research article

Treatment delay and associated factors among adults with drug resistant tuberculosis at treatment initiating centers in the Amhara regional state, Ethiopia

Research Article

Genomic epidemiology supports multiple introductions and cryptic transmission of Zika virus in Colombia

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits